BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15199763)

  • 1. [Septic shock].
    Grinev MV; Bagnenko SF; Kulibaba DM; Gromov MI
    Vestn Khir Im I I Grek; 2004; 163(2):12-7. PubMed ID: 15199763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Latest results of intensive care of sepsis, septic shock and multiple organ injuries].
    Incze F
    Orv Hetil; 1999 Mar; 140(10):515-20. PubMed ID: 10323066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-negative septicemia and shock.
    Craig CP
    Compr Ther; 1982 Feb; 8(2):13-8. PubMed ID: 7067384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of septic shock with immunotherapy.
    Smith AL
    Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current concepts in the pathogenesis and treatment of abortion and septic shock. II. The physiopathological bases and outlook in the management of septic shock].
    Figueroa Damian R; Arredondo García JL
    Ginecol Obstet Mex; 1993 Dec; 61():337-43. PubMed ID: 8119603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome.
    Manley MO; O'Riordan MA; Levine AD; Latifi SQ
    Shock; 2005 Jun; 23(6):521-6. PubMed ID: 15897804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupled plasma filtration adsorption in experimental peritonitis-induced septic shock.
    Sykora R; Chvojka J; Krouzecky A; Radej J; Kuncova J; Varnerova V; Karvunidis T; Novak I; Matejovic M
    Shock; 2009 May; 31(5):473-80. PubMed ID: 18827747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Septic shock with purpura fulminans after a dog bite].
    Völl K; Haase G; Fritz H; Riebe J; Huszka C; Kindler J
    Dtsch Med Wochenschr; 2007 Jun; 132(24):1321-4. PubMed ID: 17551886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of immunity in infectious-toxic shock in patients with peritonitis].
    Ge'lfand BR; Gologorskiĭ VA; Ershov VL; Lopukhin SIu; Zhadkevich MM
    Vestn Khir Im I I Grek; 1989 May; 142(5):23-6. PubMed ID: 2800209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infectious-toxic shock in peritonitis (pathogenetic mechanisms and main methods of treatment)].
    Savel'ev VS; Gologorskiĭ VA; Gel'fand BR
    Vestn Khir Im I I Grek; 1987 Aug; 139(8):3-10. PubMed ID: 3433614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical aspects of toxic-septic shock in peritonitis].
    Grinev MV; Kulibaba DM; Novozhilov VN
    Vestn Khir Im I I Grek; 1995; 154(1):7-11. PubMed ID: 7792998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure.
    Tojimbara T; Sato S; Nakajima I; Fuchinoue S; Akiba T; Teraoka S
    Ther Apher Dial; 2004 Aug; 8(4):286-92. PubMed ID: 15274679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
    Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
    J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
    Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
    Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.
    Nguyen HB; Corbett SW; Menes K; Cho T; Daugharthy J; Klein W; Wittlake WA
    Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of appendicular peritonitis complicated by septic shock in childhood].
    Gumerov AA; Mironov PI; Mamleev IA; Viktorov VV; Biriukov AV
    Vestn Khir Im I I Grek; 1997; 156(1):91-3. PubMed ID: 9163205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology and prophylaxis of septic infectious complications in patients from critical and intensive therapy surgical units].
    Akinkin VG; Klimova GM; Kliuzhev VM; Karpun NA; Tikhonov IuG; Luk'ianets OB; Zhuravlev AG; Korotchenko SV
    Ter Arkh; 2006; 78(11):30-5. PubMed ID: 17195523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Why is immune therapy in sepsis unsuccessful?].
    van Deventer SJ
    Ned Tijdschr Geneeskd; 1995 Mar; 139(11):548-9. PubMed ID: 7700389
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endolymphatic therapy of peritonitis].
    Akhundov IT
    Khirurgiia (Mosk); 1998; (7):17-9. PubMed ID: 9791964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined therapy of patients with sepsis resulting from peritonitis].
    Korotaev GM; Zavarin IuA; Mamonov SD
    Khirurgiia (Mosk); 1982 Apr; (4):57-60. PubMed ID: 7092989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.